Digestive Diseases Noticias Destacadas Jan. 07, 2026 PRETREAT score provides clinicians with an evidence-based tool to guide post-transplant management of pCCA The Perihilar Cholangiocarcinoma Risk Estimation of Tumor Recurrence After Transplant (PRETREAT) score is designed to facilitate individualized surveillance strategies and the development of adjuvant therapy. Jan. 07, 2026 Use of simultaneous liver transplant and sleeve gastrectomy in managing patients with obesity and end-stage liver disease Durable weight loss, improved metabolic syndrome and reduced allograft steatosis were among the outcomes associated with the combined surgeries. Jan. 07, 2026 Human liver disease and the evolving role of CRISPR/Cas9 In this Q&A, Kirk J. Wangensteen, M.D., Ph.D., explains how researchers are using CRISPR/Cas9 to study and develop new therapies for human liver diseases. Jan. 07, 2026 AI-based ACE score accurately predicts decompensation and liver outcomes in patients diagnosed with cirrhosis This artificial intelligence-based noninvasive tool enhances current prognostic models and may improve risk stratification in cirrhosis management. Calculators These models are to be used by medical professionals. Publicaciones EDICIÓN IMPRESA Ver la última edición y las versiones anteriores EDICIÓN ELECTRÓNICA DEL BOLETÍN Ver la última edición y las anteriores 1 Gastric fundal mucosal ablation targets hormonal causes of obesity 2 Clinical impact of endoscopic bariatric therapies to treat MASLD 3 Examining the incidence, clinical features and outcomes of small bowel neoplasms in individuals with Crohn's disease 4 Examining the impact of herpes zoster (HZ) and HZ vaccination in patients with IBD 5 Comparing intestinal barrier function in patients with Crohn's disease or ulcerative colitis and healthy controls Tuits de MayoClinicGIHep Profesionales médicos Digestive Diseases